MAPT and early-onset autosomal dominant Alzheimer disease: Moreover, plasma P-tau217 was not measured in the present study, which has been found to more strongly correlate with Alzheimer’s disease neuropathology and have a better diagnostic ability compared with other P-tau biomarkers.